Interim Data Demonstrate Meaningful Reduction of All-Cause Mortality with AMDS
ATLANTA, Oct. 5, 2023 /PRNewswire/ Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic.
/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today presented interim results from the.
Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Artivion, Inc. (NYSE:AORT) Q2 2023 Earnings Call Transcript August 5, 2023 Operator: Greetings, and welcome to the Artivion Second Quarter 2023 Financial Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I will […]
Operator: Greetings, and welcome to the Artivion Second Quarter 2023 Financial Conference Call. At this time, all participants are in a listen-only mode.